asa guidelines for glp-1 drugs New therapeutic agents for type 2 diabetes: anaesthetic considerations. A narrative review

Delayed gastric emptying: an unwanted effect of glucagon like peptide 1 agonists in the perioperative setting – The Anaesthesia Collective

28.44

★★★★☆4.8 (126)

Mapping the effectiveness and risks of GLP-1 receptor agonists

26.84

★★★★★4.9 (98)

GLP-1 Receptor Agonists in Gastrointestinal Practices: Enhancing Both Procedural and Patient-Related Outcomes | SN Comprehensive Clinical Medicine

26.80

★★★★★5.0 (157)

GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro) have become incredibly common in diabetes and weight-management care, and they're now showing up more and more in the perioperative setting. These

25.98

★★★★★4.7 (84)

Glucagon-like peptide-1 receptor agonists before upper gastrointestinal endoscopy and risk of pulmonary aspiration or discontinuation of procedure: cohort study

20.37

★★★★★4.9 (203)

GLP-1 Agents vs Aspirin: A New Era in Colorectal Cancer Prevention

22.21

★★★★★5.0 (176)

📌 DRUGS TO STOP BEFORE SURGERY (ASA-Based Practice Summary) Preoperative drug management is crucial to prevent bleeding, hypotension, aspiration, and metabolic complications during anesthesia. 🔴 Anticoagulants • Warfarin – Stop 5 days

23.35

★★★★★4.8 (132)